Avanos Medical, Inc. Common Stock (AVNS)
24.59
-0.04 (-0.16%)
NYSE · Last Trade: Apr 15th, 1:41 PM EDT
BALA CYNWYD, Pa., April 15, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · April 15, 2026
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Avanos Medical, Inc. (NYSE: AVNS) to affiliates of American Industrial Partners. Under the terms of the proposed transaction, shareholders of Avanos will receive $25.00 in cash for each share of Avanos that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
By Kahn Swick & Foti, LLC · Via Business Wire · April 15, 2026
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Avanos Medical, Inc. (NYSE: AVNS) to affiliates of American Industrial Partners for $25.00 per share in cash.
By Halper Sadeh LLC · Via Business Wire · April 14, 2026